Key result
This article provides a general overview of implantable cardioverter defibrillator therapy for the prevention of sudden cardiac death.
Provides an overview of ICD therapy for healthcare professionals managing patients at risk of sudden cardiac death.
Sudden cardiac death (SCD) is a major clinical and public health problem in the United Kingdom. Most deaths are related to ventricular tachycardia (VT) or ventricular fibrillation (VF). The implantable cardioverter defibrillator (ICD) actively senses and can terminate life threatening arrhythmias automatically, preventing sudden death. Expanded indications for ICD therapy is likely to result in an increase in the number of ICD patients requiring treatment and receiving care in a variety of health care settings therefore it is important that health care professionals dealing with these patients have an understanding of the device. The purpose of this article is to provide an overview of ICD therapy.
No takes yet. Share an insight, caveat, or question.
Tracey Bowden (2008) conducted a review in Sudden cardiac death. Implantable cardioverter defibrillator (ICD) therapy was evaluated. This article provides a general overview of implantable cardioverter defibrillator therapy for the prevention of sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: